A Legal Test for the Pharmaceutical Company Practice of “Product Hopping”

Overview of attention for article published in The AMA Journal of Ethic, August 2015

Altmetric Badge

Mentioned by

twitter: 3 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 6 X posts from 3 X users, with an upper bound of 48,390 followers.

Can a pharmaceutical company discontinue the formulation of a drug whose patent is about to expire in order to force consumers to change to its newly patented replacement drug? https://t.co/fwuWeDzPhs

08 Aug 2019

Reply Repost Favourite

"product hopping" in pharmaceuticals biz: one more reason for patent reform? http://t.co/9K3h49Fan4 #medethics #healthlaw

16 Sep 2015

Reply Repost Favourite

RT @815wrldtrvlr: Read The bioethics Daily http://t.co/O1ew7Wp0P4

24 Aug 2015

Reply Repost Favourite

Read The bioethics Daily http://t.co/O1ew7Wp0P4

24 Aug 2015

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.